台股 » 個股 » 訊聯 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

訊聯

(1784)
可現股當沖
  • 股價
    83.1
  • 漲跌
    ▲2.3
  • 漲幅
    +2.85%
  • 成交量
    221
  • 產業
    上櫃 生技醫療類股
  • 119人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     
訊聯 (1784)籌碼相關-凱基-中山 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

凱基-中山 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/16182.2000.0082.2014550.22%
2025/01/15182.8800.0081.9014600.22%
2025/01/1400.00184.0084.10-1460-0.22%
2025/01/131.182.71185.4079.600.14570.01%
2025/01/10182.5000.0082.6014510.22%
2025/01/08183.0000.0083.5014650.21%
2024/12/261.181.4500.0080.901.15250.21%
2024/12/2500.00179.6080.30-1521-0.19%
2024/12/20179.8000.0079.1015440.18%
2024/12/19179.402980.5579.50-28547-5.11%
2024/12/183782.481682.4382.40215483.83%
2024/12/16384.0700.0082.0035980.50%
2024/12/13187.9000.0087.2015870.17%
2024/12/12293.9500.0092.6025800.34%
2024/12/11298.08397.7097.60-1568-0.17%
2024/12/10193.2000.0093.8015590.18%
2024/12/09194.0000.0092.3015610.18%
2024/12/06396.5700.0095.0035600.53%
2024/12/05299.4500.0099.6025520.36%
2024/12/042102.004102.10100.50-2550-0.36%
2024/12/0300.00897.3095.70-8521-1.53%
2024/12/02196.601096.3096.50-9523-1.72%
2024/11/29297.40196.4097.0015190.19%
2024/11/2800.00890.6890.60-8512-1.56%
2024/11/26194.8000.0095.2015380.19%
2024/11/25897.901.198.1597.406.95651.21%
2024/11/21195.20197.7093.3005840.00%
2024/11/18287.30288.1588.7006270.00%
2024/11/13190.10190.1089.5006430.00%
2024/10/25195.00096.4094.8019270.11%
2024/10/24196.50199.8096.2009830.00%
2024/10/22295.251.196.8797.400.91,0670.08%
2024/10/2100.00194.4095.10-11,156-0.09%
2024/10/16095.0000.0094.5001,5540.00%
2024/10/11195.2000.0090.9011,5710.06%
2024/10/09197.4000.0096.1011,5850.06%
2024/09/303101.831106.00100.0021,7060.12%
2024/09/26199.201100.0098.5001,9640.00%
2024/09/231100.5000.00100.0012,2430.04%
2024/09/2000.001102.00101.00-12,278-0.04%
2024/09/1920109.280.1106.00102.50202,2880.87%
2024/09/180.1114.0000.00116.500.12,2730.00%
2024/09/1600.000106.00106.0002,2980.00%
2024/09/0900.007104.57105.50-72,499-0.28%
2024/09/030115.0000.00113.5002,6340.00%
2024/08/301117.9500.00116.5012,7630.04%
2024/08/291.1120.8800.00118.001.12,8210.04%
2024/08/261118.5048118.05120.50-472,986-1.57%
2024/08/2300.002114.25115.00-23,010-0.07%
2024/08/221114.5000.00114.5013,0030.03%
2024/08/213114.6700.00117.0032,9980.10%
2024/08/2067116.9624121.19116.00432,9731.45%
2024/08/153113.0000.00113.0032,9360.10%
2024/08/131107.001110.50113.5002,9810.00%
2024/08/123113.001114.50112.0022,9620.07%
2024/08/094109.001109.00107.5032,9260.10%
2024/08/071108.001105.00108.5002,9060.00%
2024/08/06198.3011103.50103.00-102,890-0.35%
2024/08/056100.973100.0099.5032,8530.11%
2024/08/025112.0000.00110.5052,8180.18%
2024/08/013119.501120.00117.0022,8020.07%
2024/07/301114.0027118.59116.50-262,779-0.94%
2024/07/2929114.482115.25113.50272,7480.98%
2024/07/261124.501126.00126.0002,6920.00%
2024/07/231130.5026132.37132.00-252,666-0.94%
2024/07/2218141.332144.25136.00162,6470.60%
2024/07/1914151.962158.07145.50122,5720.46%
2024/07/181157.002156.05161.50-12,302-0.04%
2024/07/171147.0000.00147.0012,2110.05%
2024/07/1600.001144.00141.50-12,198-0.05%
2024/07/153144.3300.00143.5032,1960.14%
2024/07/121144.001139.00139.0002,1770.00%
2024/07/1100.002145.50140.00-22,163-0.09%
2024/07/102144.500148.00147.5022,1440.09%
2024/07/094.1153.913148.50143.501.12,1300.05%
2024/07/0800.001146.00146.00-12,083-0.05%
2024/07/052133.001137.50133.0012,0390.05%
2024/07/0400.001135.50135.50-12,027-0.05%
2024/07/033133.8300.00133.0032,0080.15%
2024/07/0200.006135.50140.00-61,935-0.31%
2024/06/281122.004126.00127.00-31,623-0.18%
2024/06/2600.0012102.01105.00-121,428-0.84%
2024/06/25194.3000.0095.6011,3880.07%
2024/06/24295.45195.6094.2011,3710.07%
2024/06/21595.8810096.9093.70-951,351-7.03%
2024/06/202598.3100.0099.40251,3081.91%
2024/06/19395.37896.1994.20-51,279-0.39%
2024/06/18396.47794.3496.10-41,242-0.32%
2024/06/173191.5100.0091.50311,1952.59%
2024/06/14688.571486.4287.70-81,153-0.69%
2024/06/133186.161585.1185.30161,1251.42%
2024/06/12183.0000.0083.4011,0690.09%
2024/06/111683.79386.3082.80131,0511.24%
2024/06/072484.812685.9883.00-21,017-0.20%
2024/06/062582.78682.2081.20199691.96%
2024/06/05482.052.282.2687.001.89070.20%
2024/06/04784.66282.3080.0058360.60%
2024/06/031184.80684.3585.0057730.65%
2024/05/31781.27580.0282.4026900.29%
2024/05/30377.8000.0077.3036070.49%
2024/05/2900.00472.1374.00-4547-0.73%
2024/05/27168.6000.0068.6014960.20%
2024/05/23168.8000.0067.2014960.20%
2024/05/22170.5000.0069.6014870.20%
2024/05/2000.00371.3771.70-3471-0.64%
2024/05/17169.704.168.9869.90-3.1454-0.68%
2024/05/14166.1000.0065.9014180.24%
2024/05/13166.4000.0065.5014150.24%
2024/05/1000.00166.9066.30-1413-0.24%
2024/05/09166.2000.0065.6014040.25%
2024/05/07264.75165.9065.9014020.25%
2024/05/06166.40167.9066.7003960.00%
2024/05/03266.0000.0065.9023850.52%
2024/05/02067.00267.8066.50-2380-0.51%
2024/04/30164.3000.0064.2013620.28%
2024/04/29165.6300.0065.1013620.29%
2024/04/26266.75171.5066.4013550.28%
2024/04/2500.00867.3569.40-8309-2.59%
2024/04/24363.0700.0063.1032911.03%
2024/04/2300.00264.7064.10-2288-0.69%
2024/04/2200.00361.5760.80-3278-1.08%
2024/04/19158.8000.0058.8012810.35%
2024/04/16161.7000.0061.4012810.36%
2024/04/15162.8000.0063.6012780.36%
2024/04/11264.7000.0064.5022750.72%
2024/04/10166.4000.0066.2012730.37%
2024/04/0800.00166.9066.50-1270-0.37%
2024/04/03164.0000.0064.5012620.38%
2024/04/0200.00464.4065.30-4257-1.55%
2024/03/29363.0000.0062.4032541.18%
2024/03/26262.5500.0062.1022520.79%
2024/03/221263.9500.0064.20122564.68%
2024/03/21165.5000.0064.4012580.39%
2024/03/2000.00166.1066.00-1251-0.40%
2024/03/1900.00364.3063.80-3240-1.25%
2024/03/1200.00162.3062.80-1231-0.43%
2024/03/08160.6000.0061.1012310.43%
2024/03/05162.8000.0062.7012260.44%
2024/03/04162.5000.0062.5012240.45%
2024/02/2600.00263.1063.70-2228-0.88%
2024/02/23161.9000.0061.9012210.45%
2024/02/22161.3000.0061.8012220.45%
2024/02/21162.0000.0062.0012200.45%
2024/02/2000.00462.6562.30-4215-1.86%
2024/02/1900.00161.5060.40-1202-0.49%
2024/02/1500.00159.5059.40-1201-0.50%
訊聯2024年外泌體與幹細胞趨勢論壇 聚焦羊水與臍帶血應用Anue鉅亨-2024/12/25
訊聯H1外泌體業績年增1.8倍 旗下訊聯細胞智藥擬Q4登興櫃Anue鉅亨-2024/08/26
訊聯 相關文章
訊聯 相關影音